PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.00 - 0.01
0.00 - 0.02
289 / 496.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
0.00%
Gross profit growth of 0.00% while ANO.AX is zero. Bruce Berkowitz would see if minimal improvements could expand further.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-0.00%
Negative OCF growth while ANO.AX is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
No Data
No Data available this quarter, please select a different quarter.
-76.65%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-46.09%
Negative 5Y CAGR while ANO.AX stands at 76.90%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
4.52%
3Y revenue/share CAGR under 50% of ANO.AX's 60.83%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
125.06%
OCF/share CAGR of 125.06% while ANO.AX is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
14602.28%
OCF/share CAGR of 14602.28% while ANO.AX is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
31.81%
3Y OCF/share CAGR under 50% of ANO.AX's 157.39%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
99.03%
Similar net income/share CAGR to ANO.AX's 103.06%. Walter Schloss would see parallel tailwinds or expansions for both firms.
-1464.60%
Negative 5Y net income/share CAGR while ANO.AX is 120.04%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
84.00%
Below 50% of ANO.AX's 200.00%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1408.92%
3Y equity/share CAGR above 1.5x ANO.AX's 3.93%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-0.00%
We cut SG&A while ANO.AX invests at 0.00%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.